ArticleNPJ vaccines2025

Intranasal spike and nucleoprotein fusion protein-based vaccine provides cross-protection and reduced transmission against SARS-CoV-2 variants.

Zineb Lakhrif et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.